Press Releases
18 September 2019
GENEVA, Switzerland, Sept. 18, 2019 /PRNewswire/ -- The European Society of Gynaecological Oncology (ESGO) and the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) will launch on Friday, Sep 20th, 2019 the first-ever World Gynecologic Oncology Day. This year's initiative aims to raise awareness and to highlight the
Read more...18 September 2019
LOS ANGELES, Sept. 18, 2019 /PRNewswire/ -- Seeking to revolutionize the oral care industry with an innovative toothbrush designed and developed by a team of top dental industry professionals—including the former director of engineering at Sonicare—Encompass (
Read more...18 September 2019
NEW YORK, Sept. 18, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company's Chief Executive
Read more...18 September 2019
DALLAS, Sept. 18, 2019 /PRNewswire/ -- Medecision, an integrated health management solutions company that supports the health and care of more than 50 million consumers nationwide, is excited
Read more...ROYAL OAK, Mich., Sept. 18, 2019 /PRNewswire/ -- HED, a national integrated design and engineering firm, is pleased to announce the completion of the new Max and Debra Ernst Heart Center at&
Read more...18 September 2019
ATLANTA, Sept. 18, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat with analysts and investors at the upcoming Deutsche Bank 27th Annual Leveraged Finance Conference on Wednesday, September 25, 20
Read more...NEW YORK, Sept. 18, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We have recommended attorney Erik Karst of
Read more...JERSEY CITY, N.J., Sept. 18, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced completion of the last-patient/last-visit in its Phase 3 VANISH 303 study, and that it expects to release top-line data earlier than previously rep
Read more...18 September 2019
IRVINE, Calif., Sept. 18, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperature-controlled logistics solutions company dedicated to the life sciences industry, today announced the launch of its Advanced Therapy Shipper™ product line for the regenerative medicine market. The Advanced Therapy Shipp
Read more...18 September 2019
ENGLEWOOD, Colo., Sept. 18, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) phase three clinical trial titled "Evaluating the Efficacy and Safety of Ampion to treat Adults with Pain Due to Severe Osteoarthritis of the Knee", today announced 
Read more...